CIK 0001124105 · Accelerated filer<br>Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562020050
- Phone
- (858) 284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-24 | Ye Weiguo Chief Operating Officer | Option exercise | +300,000 | $0.75 | $225K | 300,000 |
| 2025-03-24 | Ye Weiguo Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −300,000 | 1,365,115 | ||
| 2025-03-21 | Ma Songjiang President | Sale 10b5-1 | −174 | $10.00 | $2K | 2,824,844 |
| 2025-03-20 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $10.09 | $20K | 2,825,018 |
| 2025-03-19 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $10.13 | $20K | 2,827,018 |
| 2025-03-18 | Ma Songjiang President | Sale 10b5-1 | −242 | $10.24 | $2K | 2,829,018 |
| 2025-03-17 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $12.09 | $24K | 2,829,260 |
| 2025-03-14 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $12.31 | $25K | 2,831,260 |
| 2025-03-13 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $11.80 | $24K | 2,833,260 |
| 2025-03-12 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $11.74 | $23K | 2,835,260 |
| 2025-03-11 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $11.40 | $23K | 2,837,260 |
| 2025-03-10 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $10.14 | $20K | 2,839,260 |
| 2025-03-07 | Ye Weiguo Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2025-03-07 | Ma Songjiang President | Sale 10b5-1 | −53 | $13.03 | $691 | 2,843,207 |
| 2025-03-07 | Ma Songjiang President | Sale 10b5-1 | −41 | $12.14 | $498 | 2,843,166 |
| 2025-03-07 | Ma Songjiang President | Sale 10b5-1 | −1,906 | $10.13 | $19K | 2,841,260 |
| 2025-03-06 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $10.80 | $22K | 2,843,260 |
| 2025-03-05 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $10.98 | $22K | 2,845,260 |
| 2025-03-04 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $10.86 | $22K | 2,847,260 |
| 2025-03-03 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $11.23 | $22K | 2,849,260 |
Page 6 of 11 · 215 trades